Olfactory Receptor 10G9: A Protein for The Sense of Smell (G219870)
Olfactory Receptor 10G9: A Protein for The Sense of Smell
Olfactory receptor 10G9 (OR10G9) is a protein that is expressed in the sweat glands and is responsible for mediating the sense of smell. It is a member of the olfactory receptor family, which includes over 300 different genes that encode for proteins that detect and respond to odors. OR10G9 is one of the most well-studied olfactory receptors, and a number of drugs that are currently in development target OR10G9.
The sense of smell is a critical aspect of human life, as it allows us to identify and respond to a wide range of smells, from the odors of food and beverages to the unpleasant smells of decay or decay products. Olfactory receptors are the molecules that detect these smells, and OR10G9 is one of the most important of these receptors. It is expressed in the sweat glands, which are responsible for regulating body temperature, and it is thought to play a key role in the sense of smell.
OR10G9 is a transmembrane protein that is composed of an extracellular portion and an intracellular portion. The extracellular portion of OR10G9 is involved in the formation of the protein-protein interaction that is responsible for its function, while the intracellular portion contains the catalytic active site that is responsible for the chemical reaction that gives the protein its unique structure.
The study of OR10G9 has led to a number of important discoveries about the biology of the sense of smell. For example, scientists have found that OR10G9 is involved in the regulation of the production of sweat, which is a critical function for maintaining a healthy body temperature. They have also found that OR10G9 is involved in the detection of a wide range of odors, including those that are associated with danger, such as the smell of smoke or the sound of a buzzing bee.
In addition to its role in the sense of smell, OR10G9 is also a potential drug target. Many drugs that are currently in development target olfactory receptors, with the goal of modulating the sense of smell or the production of sweat. These drugs work by binding to specific regions of the olfactory receptor or by modulating the activity of the receptor itself.
One of the most promising drugs that is currently in development is called OR10G9-targeting small molecule inhibitor (OSIM). This drug is designed to bind to the intracellular portion of OR10G9 and to inhibit its catalytic activity. Preclinical studies have shown that OSIM is effective in blocking the odor perception in mice, and it is expected to be effective in humans as well.
Another drug that is being developed to target OR10G9 is called OR10G9 agonist. This drug is designed to bind to the extracellular portion of OR10G9 and to stimulate the odor perception in mice. Preclinical studies have shown that OR10G9 agonist is effective in increasing the intensity of the odor perception in mice.
In addition to OSIM and OR10G9 agonist, there are several other drugs that are being developed to target OR10G9. These include compounds that are inhibitors of OR10G9 signaling, as well as compounds that are designed to modulate the activity of OR10G9 in a different way.
The study of OR10G9 is an important area of research, as it has the potential to lead to the development of new drugs that can modulate the sense of smell. Further studies are needed to understand the full biology of OR10G9 and its role in the sense of smell.
Protein Name: Olfactory Receptor Family 10 Subfamily G Member 9
Functions: Odorant receptor
The "OR10G9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10G9 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1
